Facebook Linkedin Twitter
Inside Precision Medicine Ganciclovir May Alter Patients’ DNA, But Stem Cell Transplants Don’t

Cell transplantation

Immature blood cells in leukemia.
News & Features

Ganciclovir May Alter Patients’ DNA, But Stem Cell Transplants Don’t

Malorye Branca -
0
Drs. Laura Mulloy and Anatolij Horuzsko
News & Features

Humanized Mouse Predicts Organ Transplant Success

Malorye Branca -
0
Acute lymphoblastic leukaemia, illustration
News & Features

Combo Therapy for Philadelphia Chromosome-Positive ALL Shows Positive Results

Chris Anderson -
0
Dividing stem cells (mitosis)
News & Features

Antiviral T Cells Prove Useful for Debilitating Stem Cell Transplant Side Effect

Malorye Branca -
0
Variants Mapped in Therapy-Related Myeloid Cancer May Help Guide Treatment
News & Features

Variants Mapped in Therapy-Related Myeloid Cancer May Help Guide Treatment

Malorye Branca -
0
From Bench to Clinic—The Potential of New Sequencing Tools
News & Features

From Bench to Clinic—The Potential of New Sequencing Tools

Kathy Vuksanaj -
0
TSRI and JCVI scientists conclude that the process of reprogramming is unlikely to introduce variants that would make the cells appropriate for therapy. [Source: iStock/© Archeophoto]
News & Features

Whole-Genome Study Allays Cancer Fears Surrounding Stem Cell Techniques

Inside Precision Medicine Staff Writer -
0
123Page 3 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine